These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18772723)

  • 21. Evaluation of topical cyclosporine for the treatment of dry eye disease.
    Perry HD; Solomon R; Donnenfeld ED; Perry AR; Wittpenn JR; Greenman HE; Savage HE
    Arch Ophthalmol; 2008 Aug; 126(8):1046-50. PubMed ID: 18695097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
    Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G
    Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance.
    García N; Tesón M; Enríquez-de-Salamanca A; Mena L; Sacristán A; Fernández I; Calonge M; González-García MJ
    Curr Eye Res; 2014 Jul; 39(7):673-9. PubMed ID: 24400688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
    Ousler GW; Michaelson C; Christensen MT
    Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of dry eye.
    Wang HF; Fukuda M; Shimomura Y
    Semin Ophthalmol; 2005; 20(2):53-62. PubMed ID: 16020345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two artificial tear formulations for dry eye through high-resolution optical coherence tomography.
    Garcia-Lázaro S; Belda-Salmerón L; Ferrer-Blasco T; Cerviño A; Montés-Micó R
    Clin Exp Optom; 2011 Nov; 94(6):549-56. PubMed ID: 21929716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye.
    Nichols JJ; Sinnott LT
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1319-28. PubMed ID: 16565363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OCT assessment of tear meniscus after punctal occlusion in dry eye disease.
    Ibrahim OM; Dogru M; Kojima T; Matsumoto Y; Wakamatsu TH; Tsubota K; Fujishima H
    Optom Vis Sci; 2012 May; 89(5):E770-6. PubMed ID: 22466101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore.
    Tong L; Chaurasia SS; Mehta JS; Beuerman RW
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3449-54. PubMed ID: 20181848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
    Byun YJ; Kim TI; Kwon SM; Seo KY; Kim SW; Kim EK; Park WC
    Cornea; 2012 May; 31(5):509-13. PubMed ID: 19730097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).
    Vogel R; Crockett RS; Oden N; Laliberte TW; Molina L;
    Am J Ophthalmol; 2010 Apr; 149(4):594-601. PubMed ID: 20346777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Punctal Plug Retention Rates for the Treatment of Moderate to Severe Dry Eye: A Randomized, Double-Masked, Controlled Clinical Trial.
    Brissette AR; Mednick ZD; Schweitzer KD; Bona MD; Baxter SA
    Am J Ophthalmol; 2015 Aug; 160(2):238-242.e1. PubMed ID: 25998003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of artificial tears on tear stress test.
    Khanal S; Simmons PA; Pearce EI; Day M; Tomlinson A
    Optom Vis Sci; 2008 Aug; 85(8):732-9. PubMed ID: 18677237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
    Burgess PI; Koay P; Clark P
    Cornea; 2008 May; 27(4):391-4. PubMed ID: 18434839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lubrithal (Leo viscous eye gel), precorneal residence time in normal and dry eyes.
    al-Mansouri S; Tabbara KF; Rask-Pedersen E
    Doc Ophthalmol; 1994; 88(2):187-94. PubMed ID: 7781487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of vital staining and its correlation with aqueous tear deficiency and meibomian gland dropout.
    Uchiyama E; Aronowicz JD; Butovich IA; McCulley JP
    Eye Contact Lens; 2007 Jul; 33(4):177-9. PubMed ID: 17630624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.